| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |